Recent studies have identified CD74, the cell surface form of the class II-associated invariant chain, as a binding site for the cytokine macrophage migration inhibitory factor (MIF). MIF is implicated in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus, but a functional relationship between MIF and CD74 in inflammation has not been demonstrated. We used CD74^-/-^mice to examine the role of this molecule in cellular and *in vivo*inflammatory responses, using innate immune response-dependent models to avoid confounding by the role of MHC Ii in adaptive immunity.

MIF has a demonstrated role in macrophage responses to endotoxin. LPS induced IL-1, IL-6, TNF and MIF release from WT bone-marrow macrophages. Bone-marrow macrophages lacking CD74 released significantly lower amounts of IL-1 and IL-6, but no difference in TNF release was evident. LPS-induced MIF release by WT and CD74^-/-^bone-marrow macrophages was also similar. Murine K/BxN serum-transfer arthritis is MIF dependent \[[@B1]\], and also requires the induction of IL-1. Compared with WT mice, arthritis severity (clinical score) was significantly lower in mice lacking CD74 (*P*\< 0.05). These data imply but do not demonstrate a role of CD74 in MIF-dependent inflammatory responses. To confirm the role of CD74 in responses to MIF *in vivo*, we examined a recently described action of MIF -- the induction of leukocyte trafficking \[[@B2]\]. rhMIF was injected into mouse cremaster tissue and leukocyte--endothelial interactions examined using intravital microscopy. MIF induced leukocyte adhesion and emigration *in vivo*in WT mice. In CD74^-/-^mice, in contrast, this response could not be elucidated.

These data demonstrate for the first time the role of CD74 in innate immune responses and inflammatory arthritis, and demonstrate for the first time *in vivo*the requirement for CD74 for the action of MIF. A functional role for CD74 in MIF responses in inflammation is strongly supported.
